Cargando…
mTOR Signalling in Head and Neck Cancer: Heads Up
The mammalian target of rapamycin (mTOR) signalling pathway is a central regulator of metabolism in all cells. It senses intracellular and extracellular signals and nutrient levels, and coordinates the metabolic requirements for cell growth, survival, and proliferation. Genetic alterations that dere...
Autores principales: | Tan, Fiona H., Bai, Yuchen, Saintigny, Pierre, Darido, Charbel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523933/ https://www.ncbi.nlm.nih.gov/pubmed/30970654 http://dx.doi.org/10.3390/cells8040333 |
Ejemplares similares
-
mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012) -
mTOR co-targeting strategies for head and neck cancer therapy
por: Wang, Zhiyong, et al.
Publicado: (2017) -
Head and Neck Cancer Immunotherapy: Molecular Biological Aspects of Preclinical and Clinical Research
por: Chakraborty, Rajdeep, et al.
Publicado: (2023) -
mTOR, metabolism, and the immune response in HPV-positive head and neck squamous cell cancer
por: Coppock, Joseph D., et al.
Publicado: (2016) -
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells
por: Bai, Yuchen, et al.
Publicado: (2023)